A detailed history of Frontier Wealth Management LLC transactions in 9 Meters Biopharma, Inc. stock. As of the latest transaction made, Frontier Wealth Management LLC holds 30,000 shares of NMTR stock, worth $600. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,000
Previous 30,000 -0.0%
Holding current value
$600
Previous $15,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

BUY
$0.52 - $1.0 $2,600 - $5,000
5,000 Added 20.0%
30,000 $15,000
Q4 2021

Feb 04, 2022

BUY
$0.85 - $1.33 $4,250 - $6,650
5,000 Added 25.0%
25,000 $24,000
Q1 2021

May 17, 2021

BUY
$0.84 - $2.16 $16,800 - $43,200
20,000 New
20,000 $23,000

Others Institutions Holding NMTR

About 9 METERS BIOPHARMA, INC.


  • Ticker NMTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,955,400
  • Market Cap $259K
  • Description
  • 9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...
More about NMTR
Track This Portfolio

Track Frontier Wealth Management LLC Portfolio

Follow Frontier Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frontier Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frontier Wealth Management LLC with notifications on news.